DiabetesSeriesLive

CME Presentations

Treatment of Type 2 Diabetes: A Comprehensive Approach


Presentations

  • CME
    1.0

    Office-Based Diabetes Treatments: The Foundations of Care and Use of Antidiabetes Medications

    Speakers:Richard Beaser, MD, Senior Physician; Medical Director of Continuing Medical Education
    Martin J. Abrahamson, MD, Associate Professor of Medicine
    Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Duration: 60 minutes

    Presented on: November 17, 2017

  • CME
    1.0

    Advancing to Injectable Diabetes Therapy: Practical Approaches in the Primary Care Setting

    Speakers:Richard Beaser, MD, Senior Physician; Medical Director of Continuing Medical Education
    Martin J. Abrahamson, MD, Associate Professor of Medicine
    Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Duration: 60 minutes

    Presented on: November 17, 2017


Speakers

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director of Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.

CME Information

Treatment of Type 2 Diabetes: A Comprehensive Approach


LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

Office-Based Diabetes Treatments: The Foundations of Care and Use of Antidiabetes Medications

  • Describe the pathophysiology, clinical presentation, relationship to the cardiometabolic syndrome, and natural progression of type 2 diabetes
  • Summarize indications, contraindications, potential adverse effects, cardiovascular impact, and initiation/titration methodology for treating type 2 diabetes with newer antidiabetes medications
  • Identify and strategize to overcome barriers to therapeutic advancement of diabetes treatments which may emanate from patients, providers, or practice systems issues

Advancing to Injectable Diabetes Therapy: Practical Approaches in the Primary Care Setting

  • Illustrate indications and timely therapeutic initiation and titration of newer insulins, including follow-on biologic insulins, and insulin combinations, based on an understanding of their pharmacokinetic and pharmacodynamic properties
  • Identify the clinical impact of evolving approaches to glycemic monitoring and insulin delivery utilizing newer technology, and when such technology might be indicated as part of treatment for people with diabetes
  • Identify and strategize to overcome barriers to therapeutic advancement of diabetes treatments which may emanate from patients, providers, or practice systems issues

Acknowledgement

These activities are supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Tuition

Complimentary

Accreditation Statement

The activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Joslin Diabetes Center and PlatformQ Health Education, LLC. Joslin Diabetes Center is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Live Internet Activity

Joslin Diabetes Center designates these live activities for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

Enduring Material

Joslin Diabetes Center of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

<!--

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.

-->

Date of Release/Expiration

Live Internet Activities

Friday, November 17, 2017, from 11:00 AM EST – 12:00 PM EST

   •Office-Based Diabetes Treatments: The Foundations of Care and Use of Antidiabetes Medications

Friday, November 17, 2017, from 12:00 PM EST – 1:00 PM EST

   •Advancing to Injectable Diabetes Therapy: Practical Approaches in the Primary Care Setting

Enduring Material

The enduring material will be available from November 17, 2017 – May 17, 2018.

Intended Audience

Primary Audience: Primary care providers including physicians, nurse practitioners and physician assistants

Secondary audience: Non-diabetes specialists who care for significant numbers of people with diabetes such as cardiologists and nephrologists, as well as certified diabetes educators (registered nurses, registered dieticians, exercise physiologists) and pharmacists

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 2 hours to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Faculty Disclosure

As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non-healthcare-related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (eg, stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center.

The faculty and planning committee members for this program have disclosed the following:

The planners and faculty have reported the following financial relationships with commercial interests. Via Joslin internal review, any relationship deemed relevant to the content of this activity has been identified and resolved through Joslin's internal processes.

Disclosures

Presenters

Dr. Richard S. Beaser *†, Senior Staff Physician and Medical Director of CME, Joslin Diabetes Center, has no relevant financial relationships with regard to this activity.

Martin J. Abrahamson, MD, Associate Professor of Medicine, Harvard Medical School, is a consultant for Novo Nordisk and Web MD Health Services, and is a stockholder in Health IQ.

Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Tullis Tulane Alumni Chair in Diabetes; Chief, Section of Endocrinology, Tulane University Health Sciences Center, receives grant research support to Tulane from Asahi and Bayer, and honoraria for consulting and lectures from Takeda, Novo Nordisk, sanofi-aventis, Eli Lilly, AstraZeneca, and Janssen.

Planning COmmittee

Agnes Yang Lee, MD, Medical Director, PlatformQ Health Education, has no relevant financial relationships

Karen Greb–Murphy, Senior Program Manager, PlatformQ Health Education, has no relevant financial relationships.

Joslin CME Advisory Committee

Jerry Cavallerano, OD, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships

Nuha El Sayed, MD, Staff Physician and Medical Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.

Erin Kelly, M.Ed., RN, BSN, CDE, Adult Diabetes Educator, Joslin Diabetes Center, holds stock in Tandem Diabetes Care.

Melinda Maryniuk, CDE, Director, Clinical Programs, Joslin Diabetes Center, has no relevant financial relationships.

Lyle Mitzner, MD, Staff Physician, Joslin Diabetes Center, is a consultant for Conversa Health.

Kavita Seetharaman, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships.

Alissa Segal, Pharm D, CDE, CDTC, FCCP, Clinical Pharmacist, Joslin Diabetes Center, is a consultant for Lilly and Boehringer Ingelheim.

Robert C. Stanton, MD, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships

Elena Toschi, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships.

 

* Also on the Planning Committee

† Also on the CME Advisory Committee

Contact Information

Please send content inquiries to: cme@joslin.harvard.edu

For technical problems with the site or issues with your CME Certificate, please contact DiabetesSeriesLive at 877-394-1306 or at Support@DiabetesSeriesLive.com.

Disclaimers (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Joslin Diabetes Center, DiabetesSeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.